Published in Beilstein J Nanotechnol on August 10, 2016
Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science (2006) 6.42
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol (2002) 3.77
RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci U S A (2003) 3.48
The biology of influenza viruses. Vaccine (2008) 2.58
Protection against lethal influenza virus challenge by RNA interference in vivo. Proc Natl Acad Sci U S A (2004) 1.91
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine (2011) 1.87
Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjug Chem (2011) 1.32
Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine (2010) 1.24
Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers. Antimicrob Agents Chemother (2006) 1.16
Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus. J Gen Virol (2008) 1.01
Biological nano-functionalization of titanium-based biomaterial surfaces: a flexible toolbox. J R Soc Interface (2009) 0.99
Nonviral approach for targeted nucleic acid delivery. Curr Med Chem (2012) 0.97
Identification of novel conserved functional motifs across most Influenza A viral strains. Virol J (2011) 0.94
In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide. Antivir Ther (2008) 0.87
Evolution of the influenza A virus untranslated regions. Infect Genet Evol (2011) 0.86
Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1. Int Immunopharmacol (2011) 0.84
Bioconjugates for targeted delivery of therapeutic oligonucleotides. Adv Drug Deliv Rev (2015) 0.83
Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus. Antiviral Res (2010) 0.83
Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic Avian Influenza A (H5N1) virus infection. Antimicrob Agents Chemother (2014) 0.81
Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Biochem Biophys Res Commun (1997) 0.81
Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin. Antiviral Res (2015) 0.80
Nanocomposites consisting of titanium dioxide nanoparticles and oligonucleotides. J Nanosci Nanotechnol (2012) 0.79
Cross-protective effect of antisense oligonucleotide developed against the common 3' NCR of influenza A virus genome. Mol Biotechnol (2013) 0.77
Knockdown of different influenza A virus subtypes in cell culture by a single antisense oligodeoxyribonucleotide. Int J Antimicrob Agents (2015) 0.77
High-performance method for specific effect on nucleic acids in cells using TiO2~DNA nanocomposites. Sci Rep (2012) 0.77